AzTrials
AzTrials

Traumatic Brain InjuryREACH TBINCT06111794

The REACH Intervention for Caregivers of Veterans and Service Members With TBI

A study testing REACH TBI in people with Traumatic Brain Injury and Caregiver, run by University of Virginia at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This randomized waitlist control trial will evaluate the effects of a psychoeducational intervention called Resources for Enhancing All Caregivers' Health - Traumatic Brain Injury (REACH TBI) to decrease caregiver strain (primary outcome) and improve caregiver self-efficacy, anxiety, depression, and health care… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Traumatic Brain Injury, Caregiver
What is being tested?
REACH TBI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteUnited States
Study dates
12 Jul 2024to Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • To be eligible for the study, the participant must:
  • identify as a primary caregiver for a V/SM who sustained a TBI at least 6 months prior;
  • identify as a primary caregiver who has provided care for a V/SM with TBI for at least 6 months;
  • provide some level of daily supervision or assistance with either a physical, cognitive, or behavioral issue they think is likely related to TBI;
  • believe that at least half of their caregiving responsibilities are likely related to TBI rather than another health condition(s); and
  • endorse a score of at least high burden (a score of 8 or higher) on the Zarit Burden Inventory-4.

Who cannot join

  • no telephone;
  • current diagnosis of schizophrenia or other major mental illness;
  • auditory impairment that would make telephone use difficult; or
  • the caregiver believes that more than half of their caregiving for the V/SM is for issues related to another health condition(s) rather than TBI.

Trial locations and contacts

1 site in 1 country.

Paul B Perrin, PhD contact

(434) 982-2600

perrin@virginia.edu

United States1 site, 1 recruiting
  • Tampa VA Medical Center

    Tampa, Florida, 33612

    Risa Nakase-Richardson, PhD

    Recruiting

Other trials in United States

About this study

Official title: The REACH Intervention for Caregivers of Veterans and Service Members With TBI: Efficacy and Implementation Planning Across the VA Polytrauma System of Care

This randomized waitlist control trial will evaluate the effects of a psychoeducational intervention called Resources for Enhancing All Caregivers' Health - Traumatic Brain Injury (REACH TBI) to decrease caregiver strain (primary outcome) and improve caregiver self-efficacy, anxiety, depression, and health care frustrations (secondary outcomes). This study will modify and adapt an award-winning caregiver intervention, Resources for Enhancing All Caregivers Health in the Department of Veterans Affairs (REACH VA), to support the needs of Caregivers of Veterans and Service Members with TBI.

Being tested
REACH TBI
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REACH TBIOther

    Resources for Enhancing All Caregivers' Health - Traumatic Brain Injury (REACH TBI) is a six-session, telephone intervention for Caregivers of Veterans and Services Members with TBI. The intervention focuses on problem solving training, stress management, and psychoeducation. Trained Program Coaches will deliver the REACH TBI intervention by meeting one-on-one via telephone with participants.

Study groups in NCT06111794
Study groupRoleWhat they receive
REACH TBIExperimentalParticipants will receive the REACH TBI psychoeducational intervention.
Receives: Other: REACH TBI
Waitlist ControlActive comparatorParticipants will receive the REACH TBI psychoeducational intervention.
Receives: Other: REACH TBI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. TBI-CareQOL Caregiver Strain - Short Form 6a

    It assesses caregiver strain in caregivers of individuals with TBI. Values range from 6-30, with higher scores indicating greater strain/worse outcome.

    Measured: Baseline; 3 months (post-intervention); 6 month follow-up

Secondary outcomes (4)
  1. Patient-Reported Outcomes Measurement Information System Emotional Distress - Depression - Short Form 4a

    It assesses caregiver depression. Values range from 8-40, with higher scores indicating greater depression/worse outcome.

    Measured: Baseline; 3 months (post-intervention); 6 month follow-up

  2. Patient-Reported Outcomes Measurement Information System Emotional Distress - Anxiety - Short Form 4a

    It assesses caregiver anxiety. Values range from 7-35, with higher scores indicating greater anxiety/worse outcome.

    Measured: Baseline; 3 months (post-intervention); 6 month follow-up

  3. Patient-Reported Outcomes Measurement Information System - General Self-Efficacy

    It assesses caregiver self-efficacy. Values from range 10-50, with higher scores indicating greater self-efficacy/better outcome.

    Measured: Baseline; 3 months (post-intervention); 6 month follow-up

  4. TBI-CareQOL Health Care Frustration - Self - Short Form 6a

    It assesses frustrations a TBI caregiver has had with health care services. Values range from 6-30, with higher scores indicating greater frustration with services received/worse outcome.

    Measured: Baseline; 3 months (post-intervention); 6 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2023
  2. Study start12 Jul 2024
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
This study uses a treatment/waitlist-control crossover repeated-measures design.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06111794
Sponsor's protocol ID
CDMRP-TP220091
Acronym
REACH TBI
Status last verified
Aug 2024
First submitted
26 Oct 2023
Last updated
9 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data are available to other researchers via FITBIR.

Questions about this trial

What is this clinical trial studying?

A study testing REACH TBI in people with Traumatic Brain Injury and Caregiver, run by University of Virginia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paul B Perrin, PhD ((434) 982-2600, perrin@virginia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

TBI-CareQOL Caregiver Strain - Short Form 6a (time frame: Baseline; 3 months (post-intervention); 6 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in